| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |